|
At Memorial Sloan-Kettering, a team of more than 20 specialists work together in a multidisciplinary team to provide the best possible clinical care. Eradicating Cancer, Preserving FunctionWe offer the most advanced treatment options not only to eradicate the disease but to preserve patients' ability to function normally. Our surgeons have developed new techniques that preserve bowel, bladder, and sexual function. These treatment advances have reduced the number of patients requiring a permanent colostomy after rectal surgery to only 10 percent.
Clinical ResearchIn chemotherapy, Memorial Sloan-Kettering research helped establish the efficacy of irinotecan, the first new drug for colorectal cancer in 40 years. In some patients, this drug shrinks metastatic tumors when other treatment fails. Our researchers led an international trial demonstrating that irinotecan in combination with fluorouracil and leucovorin was a more effective first-line therapy for advanced colorectal cancer, and they are now leading a large study to evaluate the combination's effectiveness in earlier-stage colorectal cancer. Oxaliplatin is another new drug in the treatment of colorectal cancer available in a clinical research program. New Technologies for Advanced CancersPatients whose disease has spread to the liver benefit from a comprehensive program that includes doctors from colorectal surgery, hepatobiliary surgery, and medical oncology who work together to maximize long-term survival.
|